会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 41. 发明专利
    • DE60133394T2
    • 2009-04-23
    • DE60133394
    • 2001-06-22
    • CERAMOPTEC GMBH
    • MOSER JOERG G
    • A61K31/5415A61K31/724A61K41/00A61K47/48A61P35/00
    • The present invention provides a drug delivery system wherein a "parachute" structure is coupled to a therapeutic compound. The "parachute" structure comprises hydrophilic branched molecules with a defined action diameter. The complex (a parachute structure coupled with a therapeutic compound) is either fixed at a cell membrane or delivered to a defined distance from the membrane within the cell. The membrane-anchoring/localizing effect of the parachute is achieved by hydrophilic structures linked with a branching unit of desired therapeutic compounds. Furthermore, the parachute structures can be connected by a spacer (e.g. beta-amino acids, gamma-amino butyric acid, or poly-amino acids) instead of directly binding to the therapeutic compound, so that the therapeutic compounds can be localized within the cells at a defined distance from the cell membrane. A spacer containing a breaking point can determine the time span, during which the drug exhibits its therapeutic activity. The hydrophilic residues can also carry signals for targeting the parachute-therapeutic complex to a defined tissue type. This can be mediated by an antibody which is specific for a tumor marker. Alternatively, a Biotin can be attached at C6 position of the sugar and then react with an Avidin-labeled tumor-specific antibody. The parachute function may also be achieved by other, more bulky hydrophilic structures such as oligosaccharides connected to the branching unit. Such sugar oligomers have specific attachment points to cell selectins, and therefore do not need additional molecular structures to target a specific tumor tissue. The use of the parachute structure gives the advantages of being able to localize a photosensitizer or chemotherapeutic drug at the site within a cell where it can destroy the tumor cell most effectively. This reduces the level of necessary systemic doses of the drugs, promotes drug excretion, and therefore considerably reduces side effects of the therapy.
    • 47. 发明专利
    • DE20311002U1
    • 2003-09-18
    • DE20311002
    • 2003-07-17
    • CERAMOPTEC GMBH
    • G02B6/42G02B6/36A61N5/00
    • A safe connection system for coupling radiation from radiation sources, such as lasers, into optical fibers is provided. The system prevents the accidental use of standard optical fibers with radiation sources that require fibers capable of transmitting high power or other radiation with unique characteristics. Because often the fibers for use with high power lasers, for example, may also be used with standard lasers, the system preserves the interchangeability of standard connection systems such as SMA by providing connectors that can properly fit both in standard receptacles and in the receptacles of the present invention. Thus, this connection system preserves the advantages of a standard laser-fiber connection system while increasing the safety of such systems, where it is necessary.
    • 50. 发明专利
    • DE69523094T2
    • 2002-07-11
    • DE69523094
    • 1995-06-08
    • CERAMOPTEC GMBH
    • KRIVOSHLYKOV SERGEJ G
    • G02F1/01G02F1/095
    • The present invention is directed at an all-fiber in line isolator. The basic isolator includes a single-mode optical fiber, a multimode waveguide, a coil or other traditional means to generate a magnetic field, and a fiber block or other traditional means to couple the fiber to the waveguide. In one embodiment, the fiber has a core and a cladding, and maintains a circular state of light polarization. The fiber has a coupling region where the cladding is partially removed. The waveguide evanescently couples to the fiber along the coupling region. The waveguide has magneto-optical properties such that applying a magnetic field along it causes backward propagating light to transfer to the waveguide with minimal disturbance to forward propagating light. Other embodiments using birefringent optical fibers are disclosed as well.